Is Urolithin A FDA Approved? What It Really Means

Short answer: no dietary supplement is "FDA approved" — not urolithin A, not vitamin C, not your daily multivitamin. That sounds alarming until you understand how the FDA actually works. "FDA approved" is a specific legal status reserved for prescription drugs and a handful of other products. Supplements live under an entirely different rulebook, and the absence of an approval stamp is the norm, not a warning sign. Here is what the label you're looking for really means, where urolithin A stands with regulators, and the quality signals that matter far more than a phrase that legally can't exist.

The honest answer, and why it isn't a red flag

If you've searched "is urolithin A FDA approved," you've probably noticed some product listings that imply it — and others that carefully avoid the phrase. The careful ones are correct. Under U.S. law, the Food and Drug Administration does not pre-approve dietary supplements for safety or effectiveness before they reach shelves. That's true across the entire category. So when a brand claims its supplement is "FDA approved," it is either misusing the term or referring to something narrower, like a manufacturing facility that has been inspected. The compound itself is not, and cannot be, "approved" the way a new pharmaceutical is.

This trips people up because we're used to "FDA approved" as shorthand for "trustworthy." In the supplement world, that shortcut breaks down. The meaningful questions aren't "did the FDA approve it?" — they're "is there a credible safety framework behind this ingredient, what does the human research show, and can I verify what's actually in the bottle?" Urolithin A has real answers to all three, which is a more useful lens than an approval label that no supplement carries.

How the FDA actually regulates supplements

The framework comes from the Dietary Supplement Health and Education Act of 1994, usually shortened to DSHEA. This law created a separate regulatory lane for supplements, distinct from both drugs and conventional food additives. Under DSHEA, the manufacturer — not the FDA — is responsible for ensuring a supplement is safe and that its label claims are truthful and not misleading before it's sold. The FDA's role is largely post-market: it monitors the marketplace, inspects facilities, reviews adverse-event reports, and can take enforcement action against products that turn out to be unsafe, adulterated, or misbranded.

In practice that means the agency has real teeth, but it uses them after a product is on the market rather than as a gatekeeper before launch. This is very different from the drug pathway, where a manufacturer must run years of clinical trials and submit an enormous evidence package for the FDA to review and formally approve before a single dose can be sold. Supplements skip that gate by design — which is exactly why "FDA approved" doesn't apply to them.

"Approved" versus "regulated" — the distinction that matters

Supplements are regulated; they are not approved. Those aren't the same thing, and the gap between them is where confusion lives. "Regulated" means there are binding rules a company must follow: manufacturing standards, labeling requirements, restrictions on the kinds of claims that can be made, and the ongoing possibility of FDA enforcement. "Approved" means a government reviewer examined a specific product's evidence and signed off before sale. Urolithin A supplements are firmly in the first bucket. Any brand that dresses that up as the second is stretching the truth.

What GRAS status is — and why urolithin A has it

There is a legitimate FDA touchpoint for urolithin A, and it's worth understanding precisely because it's easy to overstate. It's called GRAS, or "Generally Recognized As Safe." GRAS is a safety designation for substances added to food. A company can compile the scientific evidence that an ingredient is safe at intended use levels and submit a GRAS notification to the FDA; the agency reviews it and, if satisfied, issues a letter stating it has "no questions" about the conclusion.

For urolithin A, this happened: the FDA responded to a GRAS notice for the ingredient (filed as a branded form of urolithin A) with a no-objections letter, meaning the agency did not challenge the safety conclusion for its notified food uses. That's a genuine, verifiable regulatory milestone — and it's a meaningful one, because it reflects a documented safety review. But two honest caveats belong right next to it. First, GRAS is about safety in food, not about proving a supplement works — it says nothing about effectiveness. Second, GRAS is not the same as "FDA approved"; it's a distinct, narrower pathway. So the accurate way to describe urolithin A is: an ingredient with a recognized safety framework behind it, not an "FDA-approved" product.

What the human research actually shows

Because "approved" is off the table, the real substance of the question is the evidence. Here it helps to separate human trials from earlier laboratory work, because they carry very different weight.

On the human side, the picture has grown steadily. A first-in-human trial by Andreux and colleagues (2019, Nature Metabolism) reported that urolithin A was safe and well tolerated at doses up to 1,000 mg per day, and that it produced a measurable mitochondrial gene-expression signature in participants. A randomized study in older adults (Liu, D'Amico and colleagues, 2022, JAMA Network Open) over roughly four months looked at markers of muscle endurance. Singh and colleagues (2022, Cell Reports Medicine) studied middle-aged adults over four months with 500 mg and 1,000 mg arms, examining muscle strength and exercise performance. More recently, a randomized, placebo-controlled trial (2025, Nature Aging) reported over about 28 days that urolithin A supported the mitochondrial health of immune cells in midlife adults — one strand of research into "inflammaging." A 2024 systematic review in Ageing Research Reviews pulled the human literature together.

The foundational discoveries came earlier and in the lab. Ryu and colleagues (2016, Nature Medicine) showed that urolithin A triggered mitophagy — the cellular clean-up of worn-out mitochondria — and improved measures of muscle function in animal models, along with lifespan effects in a worm model. That preclinical work is important context, but it is animal and cell research, not proof of the same effects in people. Early, preclinical research is also exploring urolithin A in areas like skin, joints, gut, brain and heart tissue; those are genuinely at an early stage and shouldn't be read as settled human outcomes.

The through-line: urolithin A is unusually well studied for a supplement ingredient, with several human trials behind it. But clinical studies and FDA approval are not the same thing. Research can support a structure/function role — helping to support mitochondrial health — without any product being "approved" to treat, diagnose, cure or prevent a disease. If you want to go deeper on the evidence, our guide to the urolithin A clinical studies lays the trials out in detail.

What "FDA approved" would actually require

It's worth picturing what the approval route even looks like, because it clarifies why supplements don't take it. To earn FDA approval, a product would have to be developed and marketed as a drug — meaning its maker intends it to treat or prevent a specific disease. That triggers the full drug-development gauntlet: preclinical testing, multiple phases of human clinical trials designed to prove both safety and efficacy for a defined medical condition, and a comprehensive application the FDA reviews before granting approval. It takes many years and enormous cost, and it results in a product regulated as medicine.

Urolithin A isn't sold as a drug, and it doesn't make disease claims — it's a dietary ingredient marketed for structure/function support, like helping to support mitochondrial and muscle health as we age. That positioning is exactly why it lives in the supplement lane and not the drug lane. Wanting an "FDA approved" longevity supplement is a bit like wanting an "FDA approved" cup of coffee: the category simply isn't built that way.

The quality signals that replace an approval stamp

If there's no approval label to lean on, how do you separate a serious product from a shaky one? This is where diligence actually pays off — and it matters, because independent testing has shown the category is uneven. A 2025 lab investigation by SuppCo purchased ten popular urolithin A products and reported that six of them failed to deliver the urolithin A stated on their labels, with some containing only a tiny fraction of the claimed amount. Several of the underperformers even carried marketplace badges. The lesson isn't "avoid urolithin A" — it's "verify the specific product." A few reliable signals:

Look for third-party testing (an outside lab confirming identity and potency), cGMP manufacturing (current Good Manufacturing Practices, the FDA's baseline rules for how supplements are made), a clinically studied dose in the 500–1,000 mg per day range rather than a fraction of it, and transparent labeling that states the actual milligrams of urolithin A per serving — not just a proprietary blend. Our quality and testing page walks through how SOMA HEALTH approaches each of these, and our broader urolithin A guide covers the ingredient from the ground up. If you're comparing options, our roundup of the best urolithin A gummies applies these same filters.

So, is it safe to take?

Safety and approval are separate questions, and it's the safety one most people are really asking underneath. In the human trials to date, urolithin A has generally been reported as safe and well tolerated at studied doses, including up to 1,000 mg per day; the GRAS review adds an additional documented safety layer for its food uses. Mild digestive complaints are the kind of thing occasionally noted with supplements generally. None of that is a substitute for personal medical advice. If you're pregnant or breastfeeding, take prescription medication, or manage a health condition, talk with your doctor or pharmacist before starting urolithin A — this guide is educational and isn't a treatment recommendation. You can also read our overview of urolithin A side effects for more.

Shop SOMA HEALTH Urolithin A Gummies →

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This guide is educational and is not a substitute for advice from a qualified healthcare provider.